Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) EBT (2016 - 2025)

Historic EBT for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to -$9.2 million.

  • Assembly Biosciences' EBT rose 433.79% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.6 million, marking a year-over-year increase of 431.56%. This contributed to the annual value of -$39.8 million for FY2024, which is 3488.52% up from last year.
  • As of Q3 2025, Assembly Biosciences' EBT stood at -$9.2 million, which was up 433.79% from -$10.2 million recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' EBT ranged from a high of -$8.8 million in Q1 2025 and a low of -$62.8 million during Q4 2021
  • Moreover, its 4-year median value for EBT was -$10.9 million (2023), whereas its average is -$17.4 million.
  • Per our database at Business Quant, Assembly Biosciences' EBT crashed by 46145.12% in 2021 and then skyrocketed by 5210.03% in 2024.
  • Assembly Biosciences' EBT (Quarter) stood at -$62.8 million in 2021, then surged by 82.59% to -$10.9 million in 2023, then rose by 4.74% to -$10.4 million in 2024, then grew by 11.67% to -$9.2 million in 2025.
  • Its last three reported values are -$9.2 million in Q3 2025, -$10.2 million for Q2 2025, and -$8.8 million during Q1 2025.